Littlewood J T, Glover V, Sandler M
Br J Clin Pharmacol. 1985 Feb;19(2):275-8. doi: 10.1111/j.1365-2125.1985.tb02644.x.
Many ethanolic drinks, especially red wine, contain potent inhibitors of phenolsulphotransferase. At a dilution of 1/75 from the original beverage, extracts from six types of red wine inhibited human platelet phenolsulphotransferase P by a mean of 99% and human platelet phenolsulphotransferase M by 12%. Such extracts had no significant effect on rat liver monoamine oxidase A or human platelet monoamine oxidase B. The inhibitors, which have not yet been identified, can be extracted into ethyl acetate at acid or neutral pH. Thus, they are not monoamines. Flavonoid phenols are plausible candidates. As phenolsulphotransferase M and P are involved in the metabolism of many phenols, including drugs, the inhibition of these enzymes could result in the enhancement of pharmacological potency and have important clinical consequences.
许多酒精饮料,尤其是红酒,含有酚磺基转移酶的强效抑制剂。从原饮料稀释至1/75时,六种红酒的提取物对人血小板酚磺基转移酶P的抑制率平均为99%,对人血小板酚磺基转移酶M的抑制率为12%。此类提取物对大鼠肝脏单胺氧化酶A或人血小板单胺氧化酶B无显著影响。这些尚未鉴定出的抑制剂在酸性或中性pH值下可被萃取到乙酸乙酯中。因此,它们不是单胺类物质。类黄酮酚是可能的候选物。由于酚磺基转移酶M和P参与包括药物在内的许多酚类的代谢,抑制这些酶可能会增强药理效力并产生重要的临床后果。